담도 : 진행 췌장암의 젬시타빈, 5-FU, 시스플라틴 복합화학요법에 관한 2상 연구

Background/Aims: Gemcitabine has been the standard regimen for advanced pancreatic cancer, but the effect on the response rate and survival is still disappointing, leading to many trials of combination chemotherapy. 5-FU and cisplatin were combined with g

Saved in:
Bibliographic Details
Published inThe Korean journal of gastroenterology Vol. 45; no. 5; pp. 348 - 353
Main Authors 최상봉, Sang Bong Choi, 이활연, Hwal Youn Lee, 유영진, Young Jin Yuh, 김성록, Sung Rok Kim
Format Journal Article
LanguageKorean
Published 대한소화기학회 30.05.2005
Subjects
5-fluorouracil; Cisplatin
Gemcitabine
Pancreatic cancer
Online AccessGet full text

Cover

More Information
Summary:Background/Aims: Gemcitabine has been the standard regimen for advanced pancreatic cancer, but the effect on the response rate and survival is still disappointing, leading to many trials of combination chemotherapy. 5-FU and cisplatin were combined with g
Bibliography:Korean Society of Gastroenterology
ISSN:1598-9992